As the chairman of New Jersey-based Cambridge Therapeutics, John Klein leverages more than two decades of experience in the pharmaceutical industry to manage the development of combination drug therapies. Over the course of his career, John Klein has received recognition as an Outstanding CEO from Mitchell & Company and has been awarded Bronze Standing by the Wall Street Transcript for his role in enhancing enterprise value.
Established in 1963 to serve the financial community, the Wall Street Transcript is a publication and website that features interviews with CEOs and executives from numerous public companies. Readers can access a searchable database with more than 25,000 CEO interviews, as well as investing strategy and industry reports. Regular contributors include prominent investment houses such as Goldman Sachs, Merrill Lynch, and Morgan Stanley.
Named by Forbes as the Best Web Site Publication for Stock Picking, the Wall Street Transcript has approximately 200,000 readers each month. To browse content and interviews, or for information on subscriptions, visit www.twst.com.